CHICAGO, Nov. 22, 2011 /PRNewswire/ -- The Female Health Company (FHCO- NASDAQ-CM) today announced that its exclusive distributor in the Republic of South Africa (RSA), Sekunjalo Investments Corporation (PTY) Ltd., has received an order from the RSA Department of Health (DOH) to supply 5 million FC2 Female Condoms for delivery as soon as possible. Shipments against the order will begin before calendar year end.
O.B. Parrish, Chairman and C.E.O. of The Female Health Company, noted that "the Company applauds South Africa for providing FC2 Female Condoms, a safe, effective product that gives women options to control their sexual health, particularly HIV/AIDS prevention".
"We are very encouraged by recent indications of demand growth from customers that distribute female condoms globally and believe the long-term outlook for the Company remains positive for three reasons: the feminization of HIV/AIDS, the complexity of developing easy-to-use alternative prevention methods, and the emergence of drug resistant strains of sexually transmitted infections (STI's)."
The FC2 Female Condom has been approved by the FDA as a Class III medical device and has been cleared by the World Health Organization for purchase by U. N. Agencies.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in the U.S. and in about 120 other countries globally. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in the U.S., the European Union, Canada, Australia, South Africa, Japan, The People's Republic of China, Spain, Mexico, Greece, Turkey and the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, The Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Somalia, Sudan, Swaziland, Ugand
|SOURCE The Female Health Company|
Copyright©2010 PR Newswire.
All rights reserved